Joel Gallant's guest appearances

Joel Gallant

The Open Forum Infectious Diseases Podcast

Medictalks

David Meltzer

Emily Oster

Aaron Kesselheim

Vinay Prasad

Andy Borowitz

Zeynep Tufekci

Paul Farmer

John Bartlett

Susan Davis

Martin Blaser

Seth Mnookin

James Cherry

Jeanne Marrazzo

Michael Saag

Eric Winer

OwlTail

In the eighth installment of the OFID podcast, Editor Paul Sax, MD, delves into the headline-making pyrimethamine (Daraprim) saga where Turing Pharmaceuticals increased the price of the recently-acquired toxoplasmosis drug from $13 to $750 a pill. Aaron Kesselheim, MD, JD, MPH, and Joel Gallant, MD, MPH, join the discussion to shed light on what is unique about the generic drug market in the U.S. that makes these dramatic price increases possible and if there will be any resolution.

<p>In the eighth installment of the <em>OFID</em> podcast, Editor Paul Sax, MD, delves into the headline-making pyrimethamine (Daraprim) saga where Turing Pharmaceuticals increased the price of the recently-acquired toxoplasmosis drug from $13 to $750 a pill. Aaron Kesselheim, MD, JD, MPH, and Joel Gallant, MD, MPH, join the discussion to shed light on what is unique about the generic drug market in the U.S. that makes these dramatic price increases possible and if there will be any resolution.</p>

An interview with Drs. Aaron Kesselheim and Joel Gallant